ACE2 and infection: Neutralizing antibodies to the spike protein and its receptor binding domain (RBD) of SARS-CoV-2 prevent the virus binding to epithelial cells in the upper airways through its receptor angiotensin-converting enzyme 2 (ACE2), providing protective immunity after infection or vaccination.